Prime Minister Narendra Modi met Indian-American entrepreneur Vivek Ramaswamy in Washington to discuss India-US relations, ...
17h
Press Trust of India on MSNPM Modi meets Indian-origin entrepreneur Vivek Ramaswamy, discusses innovation and biotechnologyPrime Minister Narendra Modi on Thursday met Indian-American billionaire entrepreneur Vivek Ramaswamy here and the two ...
As I have posted, I am a top 8 predictor on Metaculus out of 34617 people according to Metaculus for baseline accuracy. I was ...
Republican Vivek Ramaswamy will launch his bid for Ohio governor on Feb. 24 in his native Cincinnati, with ensuing events in ...
10h
Hosted on MSNBiotechs on the Brink: 2 Stocks With Huge PotentialInvestors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to ...
The experts will assess unblinded data from BEACON-IPF to figure out why a data safety monitoring board recommended ...
UNC Charlotte received the most NIH funding in the area — $56 million since the 2015 fiscal year. The university received ...
One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics (NASDAQ: GPCR), was a victim of a ...
In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal anticipated cuts to the company’s digital team.
The Crimson spoke to a range of commercial realtors, startup founders, and a commercial lab space owner to understand how the immense draw of Kendall Square has forced the myriad startup companies ...
Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results